Press releases

Biorce Appoints Life Sciences Executive as Chief Operating Officer to Support Global Growth

Biorce is strengthening its leadership team with an experienced People and Operations Executive as the company scales its AI-native approach to clinical development.

Biorce ride experience at ESMO Madrid 2026

Austin, United States - [October 13, 2026] — Biorce, the global healthtech company building AI-native tech for the entire clinical trial lifecycle, today announced the appointment of Jennifer Erfurth as Chief Operating Officer. With extensive experience leading organizations through rapid growth, international expansion, and AI transformation, Erfurth will help support Biorce as it scales its operations and continues to build the future of clinical development.

A four-time Chief People Officer and Chief Human Resources Officer, Erfurth has led People organizations through significant periods of growth at companies including ServiceNow and Align Technology. At ServiceNow, Erfurth helped lead the organization through growth from $500 million to $4.5 billion in revenue and from 5,000 to 15,000 employees. At Align Technology, Erfurth supported the company’s expansion from $300 million to $2.5 billion in revenue and into more than 30 countries. Most recently, as Chief People Officer at OPSWAT, Erfurth built AI-first People services and led enterprise AI transformation across the function.

“Biorce is at an exciting point in its journey, and scaling a company at this stage requires more than strong technology, it requires the right organization, culture, and operating model,” said Pedro Coelho, Founder and CEO of Biorce. “Jennifer Erfurth brings an exceptional track record of building organizations through periods of rapid growth and transformation. Her experience will be invaluable as we continue to scale Biorce and bring AI-native clinical development to a global market.”

Erfurth has been recognized five times as a Top 50 HR Professional, receiving the award each year from 2022 through 2026.

About Biorce

Biorce is an AI healthtech startup, building defensible AI solutions for clinical trial development. Its platform, Aika, is a continuous intelligent layer, from protocol decision to regulatory submission, enabling fewer amendments and a dramatic reduction of cost and time.

Media contact

Lynn Caroline Broeker
PR & Media collaborations
[email protected]

Get the inside track on clinical trial innovation Insights that pharma leaders actually read. No fluff.

Submit

@2026 Biorce | All Rights Reserved

Partners with

Get the inside track on clinical trial innovation Insights that pharma leaders actually read. No fluff.

Submit

@2026 Biorce | All Rights Reserved

Partners with

Get the inside track on clinical trial innovation Insights that pharma leaders actually read. No fluff.

Submit

Partners with

@2026 Biorce | All Rights Reserved